Kyle Turk.jpg

Kyle Turk

Director of Government Affairs, Natural Products Association (NPA)

Kyle Turk is the director of government affairs for the Natural Products Association (NPA), where he works with members to advance the organization’s federal and state public policy initiatives.

Latest from Kyle Turk

Ozempic Insulin Injection
Supplement Regulations
Sounding the alarm: Ozempic and government crackdowns have big implications for supplementsSounding the alarm: Ozempic and government crackdowns have big implications for supplements
byKyle Turk
Nov 6, 2023
5 Min Read
Natural Products Association shares details on states’ 2023 assault on supplements
Supplement Regulations
Natural Products Association shares details on states’ 2023 assault on supplementsNatural Products Association shares details on states’ 2023 assault on supplements
byKyle Turk
May 3, 2023
9 Min Read

All from Kyle Turk

2023.jpg
Supplement Regulations
Natural Products Association reflects on 2022, looks ahead to new year
Natural Products Association reflects on 2022, looks ahead to new year
Jan 4, 2023
|
9 Min Read
byKyle Turk
New York State Capitol Building.jpg
Supplement Regulations
NPA: ‘Radical proposals’ would limit access to dietary supplements
NPA: ‘Radical proposals’ would limit access to dietary supplements
Jul 7, 2022
|
9 Min Read
byKyle Turk
Gov't form and stamp
Supplement Regulations
Mandatory product listing means premarket approval, market destruction
Mandatory product listing means premarket approval, market destruction
Jan 13, 2022
|
8 Min Read
byKyle Turk
HSAs FSAs 2021.jpg
Supplement Regulations
Follow the path of least resistance on HSA legislation for supplements
Follow the path of least resistance on HSA legislation for supplements
Nov 17, 2021
|
4 Min Read
byKyle Turk

Recommended

Supplement Regulations
NY law targeting dietary supplements mired in CRN, NPA litigation
NY law targeting dietary supplements mired in CRN, NPA litigation

Mar 13, 2024

Supplement Regulations
FDA seeks dietary supplement listing requirement in FY25 budget proposal
FDA seeks dietary supplement listing requirement in FY25 budget proposal

Mar 12, 2024

Supplement Regulations
FDA NDI guidance: Five key takeaways
FDA NDI guidance for supplement companies: Five key takeaways

Mar 12, 2024

Market Trends & Analysis
Amway’s revenues continue decade-long slide, dropping to $7.7 billion
Amway's annual revenues drop by 5%

Mar 12, 2024

Recent headlines
Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.